NCT04117334 Determining Best Indications for Bracing for Adolescent Idiopathic Scoliosis
| NCT ID | NCT04117334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Adolescent Idiopathic Scoliosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2016-12-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2016-12-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective study for Investigating the cost-effectiveness of current bracing protocols for adolescent idiopathic scoliosis (AIS). It is hypothesized that aggressive management of adolescent idiopathic scoliosis (AIS) including early bracing at mild curve magnitudes and surgery at 40 degrees is more cost-effective while maintaining similar health quality of life. Scoliosis Research Society 22-item and EuroQol- 5 dimension questionnaires and direct/indirect medical costs will be utilized for the cost-effectiveness analysis and health related quality of life assessment. The findings of this study have the potential to improve decision-making and revolutionize care of AIS patients in Hong Kong and globally. Clinicians will be able to utilize our results to provide the best and most cost-effective timing for initiating brace treatment.
Eligibility Criteria
Inclusion Criteria: * Patients who are diagnosed with adolescent idiopathic scoliosis and are seen in the first setting with remaining growth potential (Risser 0-2), and are prescribed with either underarm (Boston) or Milwaukee bracing Exclusion Criteria: * Patients whose diagnosis is not adolescent idiopathic scoliosis, unable to comply with study follow-up and refused consent for study
Contact & Investigator
Jason Cheung, MBBS, MS
PRINCIPAL INVESTIGATOR
HKU/HA
Frequently Asked Questions
Who can join the NCT04117334 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Adolescent Idiopathic Scoliosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04117334 currently recruiting?
Yes, NCT04117334 is actively recruiting participants. Contact the research team at cheungjp@hku.hk for enrollment information.
Where is the NCT04117334 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong.
Who is sponsoring the NCT04117334 clinical trial?
NCT04117334 is sponsored by The University of Hong Kong. The principal investigator is Jason Cheung, MBBS, MS at HKU/HA. The trial plans to enroll 700 participants.